Quince Therapeutics, Inc. QNCX Q2 2025 earnings
Reported August 11, 2025 · Before market open
EPS estimate-$0.28
Next report
Aug 11, 2026 (in a month)EPS estimate-$25.40
Versus estimates
Diluted EPS
Ask the moment Quince Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Quince Therapeutics, Inc. report Q2 2025 earnings?
- Quince Therapeutics, Inc. (QNCX) reported Q2 2025 earnings on August 11, 2025 before market open.
- What were Quince Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Quince Therapeutics, Inc. reported diluted EPS of $-0.34 for Q2 2025.
- Did Quince Therapeutics, Inc. beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-0.28 by $0.06.
- How did Quince Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS declined 88.9% from $-0.18.
- Where can I find Quince Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-106535) directly on SEC EDGAR. The filing index links above go to sec.gov.